Blog

Ketamine Therapy for Anxiety and PTSD Highlighted in Resource from Moment of Clarity

Huntington Beach, California – October 17, 2025 – PRESSADVANTAGE –

Moment of Clarity has published a new resource titled “Using Ketamine for Anxiety and PTSD Treatment“, now available on their website. The article examines how ketamine therapy may support patients living with anxiety disorders and post-traumatic stress disorder (PTSD), particularly those who have not found sufficient relief through traditional treatments. The resource aims to provide patients, families, and communities with a clear understanding of where ketamine fits within modern mental health care.

Anxiety and PTSD are among the most common mental health challenges, often accompanied by symptoms that disrupt sleep, relationships, and daily functioning. Standard therapies such as medication and counseling remain effective for many, but a significant number of patients experience treatment-resistant symptoms. The publication explains how ketamine, administered in controlled clinical settings, interacts with brain receptors linked to mood regulation and may provide rapid symptom relief. Unlike conventional antidepressants that may take weeks to show benefits, ketamine has demonstrated a faster onset in certain patients.

Research supports these observations. Studies published in JAMA Psychiatry (2019) and clinical reviews from the National Institutes of Health indicate that ketamine can reduce symptoms of depression and trauma-related conditions in some individuals who did not respond to other treatments. However, the article makes clear that while ketamine is FDA-approved as an anesthetic and esketamine (Spravato) is FDA-approved for treatment-resistant depression, the use of ketamine for anxiety and PTSD remains off-label and should only be provided under careful medical supervision.

For patients in Huntington Beach, California, the resource highlights how ketamine therapy may complement existing services such as group therapy, family counseling, and psychiatric evaluations. By reducing the intensity of acute symptoms, ketamine may allow patients to engage more effectively in talk therapy and skill-building interventions. The article emphasizes that ketamine is not a replacement for these services, but a tool that can strengthen their impact.

The publication also addresses safety. Administered in licensed medical environments, ketamine therapy is closely monitored to ensure patient well-being. Common side effects, such as dizziness or mild dissociation, are typically temporary and resolve on their own. Medical supervision ensures that dosing is carefully controlled and that patients receive support throughout each session.

Another focus is the importance of trauma-informed care. Many patients struggling with PTSD also live with co-occurring conditions such as depression or substance use disorders. The article notes that ketamine therapy is most effective when integrated into comprehensive care programs that may also include cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and medication management. This integrative approach reflects a commitment to addressing both the biological and psychological aspects of recovery.

Moment of Clarity’s resource also acknowledges the stigma that can surround advanced therapies. Some patients hesitate to explore newer treatments due to fear of judgment or misconceptions about them. By providing evidence-informed explanations of ketamine’s role, the publication seeks to normalize the use of innovative therapies alongside established methods, encouraging earlier access to care.

Continuity of care is another central theme. While ketamine therapy may provide rapid relief, the resource emphasizes that lasting recovery depends on ongoing therapeutic engagement. Patients may begin with ketamine sessions but require continued counseling, family therapy, and psychiatric evaluations to build resilience and maintain progress over time.

By publishing Using Ketamine for Anxiety and PTSD Treatment, Moment of Clarity reinforces its role as a trusted provider of patient education. The article explains how ketamine therapy works, clarifies its regulatory status, reviews emerging research, and highlights its potential integration into broader treatment plans.

For individuals in Huntington Beach and the surrounding area seeking reliable information on advanced mental health options, this resource offers balanced, research-based guidance. By combining education with clinical expertise, Moment of Clarity in Huntington Beach helps patients and families explore innovative recovery pathways while maintaining confidence in the safety and effectiveness of their care.

###

For more information about Moment of Clarity Huntington Beach, contact the company here:

Moment of Clarity Huntington Beach
Marie Mello
(949) 403-6740
marie@momentofclarity.com

October 23, 2025
WhiteSands Releases New Guide Answering: How To Recognize the Early Signs of Vicodin Addiction

CLEARWATER, FL – October 17, 2025 – PRESSADVANTAGE –

WhiteSands Alcohol & Drug Rehab Clearwater has released a new online resource titled “Understanding the Signs of Vicodin Addiction“, available on their website. The article offers families and patients practical insight into identifying early warning signs of opioid misuse, the risks associated with Vicodin, and the importance of timely access to supervised withdrawal care.

The publication highlights that Vicodin, a prescription medication often used for pain relief, carries a high potential for dependence when misused. Many people may not recognize the gradual shift from prescribed use to abuse until physical and psychological symptoms are already present. The article outlines key indicators such as behavioral changes, mood swings, and withdrawal effects as important signals that medical attention is necessary. By presenting this information in clear terms, WhiteSands aims to shorten the time between the onset of symptoms and seeking treatment.

The resource underscores that opioid addiction is a medical condition, not a personal weakness. Patients who attempt to stop using Vicodin without clinical guidance often encounter intense withdrawal symptoms, including nausea, muscle pain, anxiety, and insomnia. These symptoms can quickly lead to relapse if detox is attempted outside a supervised setting. Drawing on findings from the Substance Abuse and Mental Health Services Administration (SAMHSA), the article explains that medically supported detox programs improve patient safety and increase the likelihood of successful recovery.

WhiteSands Clearwater emphasizes the importance of supervised detoxification as the foundation for effective addiction treatment. The center provides 24/7 monitoring in medically supported environments, along with access to medication-assisted protocols that ease discomfort and reduce risks during withdrawal. Detox alone, however, is not sufficient for long-term recovery. Once patients stabilize, they are encouraged to transition into comprehensive care programs that address the psychological and behavioral drivers of addiction through inpatient or outpatient therapy, relapse prevention strategies, and long-term recovery planning.

The article also explains the importance of integrating detox with evidence-based counseling. Detox clears the body of substances, but therapy addresses the underlying issues that fuel addiction. Combining these approaches ensures patients begin recovery with both physical stability and a plan for emotional and mental health support. Research from the National Institute on Drug Abuse (NIDA) is cited, noting that treatment outcomes are stronger when detoxification is followed by structured therapy and ongoing support services.

Financial accessibility is another factor addressed in the resource. The article highlights the value of treatment programs that strike a balance between affordability and clinical quality, noting that cost concerns often deter families from seeking help. By encouraging patients and their loved ones to explore programs that provide both safety and cost-effective care, WhiteSands aims to reduce the barriers that prevent people from pursuing treatment.

Local context is acknowledged throughout the publication, with attention given to the needs of Clearwater residents and the surrounding areas. Whether in coastal neighborhoods like Clearwater Beach or smaller nearby communities, the challenges of opioid misuse remain consistent: families often struggle to recognize when prescription use has become dependency, and patients may delay care until the addiction is advanced. The resource seeks to address this gap in awareness by offering guidance that is both medically accurate and accessible to all patients.

The article concludes by stressing the urgency of early intervention. Delays in addressing Vicodin misuse can lead to worsening dependence, health complications, and increased risk of overdose. By making information available online, WhiteSands aims to reach families at the critical point when questions first arise about whether a loved one may be struggling with opioid misuse.

For people searching for “drug rehab near me” or “medication-assisted detox in Clearwater,” this resource provides clear, evidence-based information rather than promotional promises. It is designed to help families make informed decisions, emphasizing that recovery begins with recognizing the signs and taking action promptly.

With the release of Understanding the Signs of Vicodin Addiction, WhiteSands Alcohol & Drug Rehab reinforces its role as both a treatment provider and an educational resource. By focusing on the warning signs of opioid misuse and the importance of supervised detox, the center continues its mission to support patients and families with compassion, clinical expertise, and a commitment to long-term recovery.

###

For more information about WhiteSands Alcohol & Drug Rehab Clearwater, contact the company here:

WhiteSands Alcohol & Drug Rehab Clearwater
Ryan Monesson
(727) 270-9970
rmonesson@wstreatment.com
1932 Drew St, Clearwater, FL 33765

October 23, 2025
SMX Tightens Its Core as the World Moves Toward Its Proof-Based Economy (NASDAQ: SMX)

NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Every investor knows the reflex. You see the words reverse split, and your instincts flinch. It’s practically Pavlovian. But sometimes, what looks like retreat is actually recalibration. And that’s exactly what’s happening at SMX (NASDAQ:SMX). The company that made “proof” a product and traceability a trillion-dollar opportunity just tightened its capital structure in a move that could position it for an entirely different kind of growth.

As of October 23, 2025, SMX’s recap will take effect, consolidating approximately 15.5 million ordinary shares into about one million. The math may look surgical, but the intent is strategic. This isn’t a desperate act of survival; it’s a precision tune-up for a company that’s been quietly building the digital backbone of global commerce.

Re-engineering the Foundation

Let’s cut through the noise. A reverse split doesn’t change a company’s fundamentals. What it does change is perception-and for SMX, perception has always been a powerful asset. The move tightens the float, raises the share price, and signals confidence that the company’s valuation story is far from over. It’s the kind of restructuring that clears static from the air, giving the real story room to breathe.

That story, by the way, is massive. SMX’s molecular marker technology is redefining authenticity, transforming physical goods into verifiable digital assets-proof instead of promise. Whether it’s plastics, metals, textiles, or electronics, the company’s system can permanently encode a material’s origin, lifecycle, and legitimacy.

This isn’t theory; it’s traction. SMX’s ecosystem already includes partnerships with Singapore’s A*STAR, CETI in France, Tradepro Group, BT-Systems and REDWAVE in Europe, NAFRA and AsureQuality in Australia, and even collaborative initiatives extending into defense and critical minerals supply chains. Add to that its ongoing work with BASF and Continental, and you begin to see a network that’s not just expanding, but compounding in influence. SMX isn’t just participating in global traceability-it’s defining it.

While others react to regulation, SMX is quietly building the infrastructure regulators will rely on. That’s not survival-it’s strategy.

A Cap Structure Built for Momentum

So why consolidate now? Because timing is everything. The reduction in outstanding shares creates a leaner, more investable structure-one that institutions can actually take a position in without tripping over penny-stock stigma. It’s also the first real sign that management is thinking two moves ahead, not just about survival, but about scalability.

SMX’s balance sheet now looks like a spring-loaded platform: compact, simplified, and ready for lift. With fewer shares on the table, each incremental achievement-new project, new geography, new validation-will have a more meaningful impact on per-share value. It’s the market’s equivalent of tightening your core before the next climb.

Proof Still Pays

Investors who’ve been around long enough know that markets often misread these moments. They see consolidation as contraction. In reality, it’s preparation. SMX isn’t trying to look bigger; it’s getting stronger. Its partnerships are multiplying across continents, its Plastic Cycle Token is evolving into the value layer of circular commerce, and its proof-based verification model is becoming the global standard for sustainability.

Reverse split or not, the business trajectory is unmistakable: up.

SMX has always been about transforming invisible data into visible truth-and now, it’s doing the same with its capital structure. What investors should see isn’t a shrinking chart, but a sharpening silhouette. Because when the foundation is this strong, consolidation isn’t a warning sign. It’s the prelude to acceleration.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “will,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company’s fight against abusive and possibly illegal trading tactics against the Company’s stock; successful launch and implementation of SMX’s joint projects with manufacturers and other supply chain participants of gold, steel, rubber and other materials; changes in SMX’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX’s ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX’s ability to successfully and efficiently integrate future expansion plans and opportunities; SMX’s ability to grow its business in a cost-effective manner; SMX’s product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX’s business model; developments and projections relating to SMX’s competitors and industry; and SMX’s approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company’s shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX’s business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX’s products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX’s filings from time to time with the Securities and Exchange Commission.

EMAIL: info@securitymattersltd.com

SOURCE: SMX (Security Matters) Public Limited

View the original press release on ACCESS Newswire

October 23, 2025
M42 Announces Agreement to Acquire Stake in U.S. Rare Earth and Precious Metals Company

Companies to Leverage Innovative AI Platform to Further Define Major Shovel-Ready Metals Resource, Poised to Become One of World’s Largest Deposits

DALLAS, TX / ACCESS Newswire / October 22, 2025 / Messier 42 LLC (“M42”), a private leading global artificial intelligence technology and digital transformation company, announces that it has entered into an agreement to acquire a minority interest in a privately developed polymetallic metal resource company based in the Western U.S., specializing in precious, rare earth and critical metals. Initial production and positive cashflow is anticipated within 12 months.

This investment presents the opportunity to leverage M42’s successful Transformational AI platform to non-invasively locate and further define the resource company’s shovel-ready metals deposit. Both companies believe that the current NI43-101 Measured Resource Report, which is expected to be upgraded to a Probable Reserve Report based on retesting of assay results using more accurate methods, could reflect one of the world’s largest precious, critical and rare earth element deposits.

“As the global race to secure critical and rare earth elements intensifies, we are thrilled to have found a domestic partner with a world-class resource right here on American soil-where we can apply our AI platform to further define and advance the understanding of these strategic assets,” said Michael Sandoval, Chief Scientist of M42. “By reducing reliance on foreign supply chains, this initiative directly supports American national security while positioning the United States to remain competitive in the global race for technological and economic leadership in the 21st century.”

“This investment and partnership with M42 AI in our company strengthens U.S. capacity to secure critical minerals and rare earths-resources that are indispensable to defense systems, advanced semiconductors, renewable energy, and next-generation technologies.” said the spokesperson for the private resource company. “We look forward to working with the team at M42 AI to utilize their AI platform to advance our project.”

The private American company has been developing their world class mine site for over 6 years and is expected to start profitable production within 12 months. In addition to producing precious metals, it is expected to mine significant grades/amounts of key critical and rare earth metals, some of which are either not produced in the US or whose supplies are imported from politically unappealing parts of the world. The management team is comprised of experienced mining and corporate developmental individuals who have successfully built this unconventional project from its inception. Ultimately, the elements contained in this discovery, will enable innovation across critical sectors of the modern U.S. economy, including semiconductors, energy, robotics, defense, and aerospace.

The agreement is subject to certain conditions precedent and is expected to close before the end of the year.

About M42

M42 is a global leader in technology solutions and digital transformation, providing innovative services across various industries. As a syndicate leveraging AI for justice, truth and fairness, M42 combines deep expertise in artificial intelligence, cloud computing, and cybersecurity to drive growth and efficiency for its clients worldwide.

Forward Looking Statements

This document contains certain forward-looking statements within the meaning of Private Securities Litigation Reform Act of 1995. Forward-looking statements, including those related to the services provided by M42 and the private resource company and the consummation of the agreement, are statements that are based on current expectations as well as the beliefs and assumptions of management as of that time with respect to future events. These statements are subject to risks and uncertainties, many of which involve factors or circumstances that are beyond M42’s control. Except as required by law, M42 does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments, or otherwise.

M42 Contacts

Matthew Selinger, Senior Partner
Integrous Communications
Email: mselinger@integcom.us
Phone: 415-572-8152
Website: https://m42.com/

Visit us on social media:

Facebook = https://www.facebook.com/m42ai/
Instagram = https://www.instagram.com/m42_ai_/
X: https://x.com/M42_AI_

SOURCE: M42

View the original press release on ACCESS Newswire

October 23, 2025
Spine Surgeon Dr. John Peloza Shared Insights on Leading a Single-Specialty ASC at Becker’s 31st Annual Meeting

Founder of Peloza Spine joined national healthcare leaders to discuss physician-led innovation and operational excellence in orthopedic ambulatory surgery centers.

CHICAGO, IL / ACCESS Newswire / October 22, 2025 / John H. Peloza, MD, founder of Peloza Spine in Chesterfield, Missouri, was among the featured speakers at the Becker’s 31st Annual ASC Meeting: The Business and Operations of ASCs, which took place October 16-18, 2025, at the Swissôtel Chicago. Dr. Peloza joined a distinguished panel of orthopedic leaders in the session titled “How to Lead a Single-Specialty Orthopedic ASC.”

The discussion examined how single-specialty orthopedic ASCs have evolved beyond efficiency to become strategic hubs for growth, innovation, and physician alignment. Panelists shared insights on expanding complex case capabilities, navigating payer friction, optimizing the patient journey, and adopting technology to strengthen outcomes and sustainability.

Drawing on his experience advancing motion-preserving spine surgery, Dr. Peloza described how surgical innovation and ASC operations needed to evolve together. He noted that the same principles driving efficiency such as team coordination, patient education, and outcome tracking were essential to supporting advanced spine procedures in an outpatient environment.

“The ASC model has redefined how we deliver orthopedic and spine care,” said Dr. Peloza. “When physicians lead these centers, we can make nimble, data-informed decisions that enhance outcomes, expand access, and align care directly with patient needs. For spine, that means investing in teams, workflows, and technology that make motion-preserving and minimally invasive procedures truly feasible in an outpatient setting.”

Joining Dr. Peloza on the panel were LoAnn Vande Leest, RN, MBA-H, CNOR, CASC, Executive Director of The Orthopaedic Surgery Center; Dave Fitzgerald, Chief Executive Officer of OrthoNY; and Jonathan Brown, MD, Board Member of U.S. Orthopaedic Partners and Orthopedic Surgeon at Bienville Orthopaedic Specialists. The session was moderated by Kelly Gooch, Senior Editor and Enterprise Lead at Becker’s Healthcare.

Becker’s 31st Annual ASC Meeting brought together more than 4,000 surgery center and hospital leaders from across the United States to discuss the most pressing trends in healthcare business and operations. Sessions covered topics ranging from payer contracting and technology adoption to physician alignment and value-based care. For more information about the event, visit https://conferences.beckershospitalreview.com/31st_Annual_ASC_Meeting_2025.

Dr. Peloza is available for interviews to discuss physician-led ASC models, motion preservation spine surgery, and the future of outpatient orthopedic care.

About Dr. John Peloza

Dr. John Peloza is a nationally recognized orthopedic spine surgeon with more than three decades of experience advancing motion preservation, minimally invasive spine surgery, and biologic disc repair. A prolific clinical researcher and innovator, he has served as principal investigator in 10 FDA-regulated trials and over two dozen randomized trials. Dr. Peloza holds 16 patents in spinal device and procedural technologies. Dr. Peloza is widely regarded as a pioneer in artificial disc replacement and has trained hundreds of surgeons in motion-preserving techniques. His work integrates clinical precision with a deep commitment to improving outcomes and quality of life for patients with complex spinal disorders.

About Peloza Spine

Peloza Spine is a specialty spine care center located within Midwest Orthopedic and Spine Specialists in Missouri, founded by Dr. John Peloza. The practice is dedicated to advancing the next generation of spinal care through a patient-centric approach that emphasizes motion preservation, surgical precision, and biologic disc regeneration. Peloza Spine provides comprehensive diagnostic services, non-operative solutions, and a full range of surgical options – including artificial disc replacement, fusion revision, and minimally invasive procedures. With a focus on restoring function and avoiding unnecessary fusion, Peloza Spine helps patients regain motion, reduce pain, and return to active living.

Media Contact:

Brandi Kamenar
Brandi Kamenar Brand Management
Email: brands@brandikamenar.com
Phone: (310) 734-6180

SOURCE: Peloza Spine

View the original press release on ACCESS Newswire

October 23, 2025
Pajar Canada Marks 60 Years With “Zig Zag” Book Chronicling Family Legacy

Canadian footwear company celebrates six decades as a family-run operation with the publication of a new book

MONTRÉAL, QC / ACCESS Newswire / October 22, 2025 / Pajar Canada today announced the release of Pajar Zig Zag Book, a new volume that traces the brand’s 60-year path as a family business and its shoemaking roots dating to 1926 in Paris. The book explores the company’s “zigs and zags” through immigration, startup challenges and growth, and how a family built an enterprise kept its focus on purpose, craft, and community.

Founded in 1963 by Paul Golbert, Pajar takes its name from the first letters of Paul, Jacques, and Rachel. The book follows the family’s immigration to Canada, the opening of the first Montreal showroom, and the launch of in-house manufacturing, while documenting how the brand built products for warmth, protection, and movement in winter conditions.

“I grew up in this company, learning each part of the craft and sending out the daily mail orders,” said Elise Golbert, chief marketing officer at Pajar Canada and a fifth-generation shoemaker. “Zig Zag is how we tell our story, honestly, with the ups, downs, and family values that continue today.”

Pajar Zig Zag Book highlights key milestones, including early imports of European footwear to the Canadian market, industry recognition, partnerships on the world stage, and global retail growth. It also outlines the brand’s design process, including materials, construction, and performance testing, as well as the values that continue to guide Pajar: endeavor, loyalty, and passion.

The book connects the company’s heritage with current collections in performance footwear and outerwear, along with loungewear and cold-weather accessories, showing how the brand’s identity has stayed consistent while evolving with new materials and techniques.

Pajar Zig Zag Book is available through Pajar Canada’s website and ships via daily mail and parcel carriers.

For additional information about Pajar, visit and shop, and follow @PajarCanada on Instagram and Facebook and @PajarOuterwear on X (Twitter).

About Pajar Canada
Pajar Canada is a fifth-generation family footwear company founded in 1963 and based in Montreal, Quebec. The brand designs, manufactures, wholesales, and retails performance fashion footwear, outerwear, and accessories rooted in a rich handcrafted shoemaking heritage. Collections blend technical materials and craft to deliver warmth, protection, and comfort in cold climates. In 2023, Pajar marked its 60th anniversary with the publication of the Pajar Zig Zag Book, which documents the family’s story and design legacy. Today, the company serves customers globally through e-commerce, retail, and select partners.

Media contact

Name: Elise Golbert
Email: info@pajar.com
Phone: 1-844-932-1963
Website: https://ca.pajar.com/

SOURCE: Pajar Canada

View the original press release on ACCESS Newswire

October 23, 2025
A Whole New Ballgame: Victory+ and IMAX Partner for First-Ever Live MLB in IMAX Enhanced
Rangers vs. Angels pilot delivers next-level immersive viewing and strong engagement on UHD devices

DALLAS, TX AND NEW YORK, NY / ACCESS Newswire / October 22, 2025 / Victory+™, the premium sports streaming platform from A Parent Media Co. Inc. (APMC), and IMAX Corporation, today announced the successful completion of a first-of-its-kind pilot, streaming the Texas Rangers vs. Los Angeles Angels series (August 25-27) in IMAX Enhanced, marking the first-ever live Major League Baseball games presented in the format.

Powered by IMAX VisionScience™ on AWS, the stream brought amplified key visual elements with richer color, sharper contrast and greater clarity, delivering an immersive experience fans could truly see and feel across select UHD-compatible platforms and devices available to Victory+ subscribers.

“By working with IMAX, we’re leading with bold innovations that make watching at home just as thrilling as being in the stadium,” said Neil Gruninger, President and CEO of APMC. “With Victory+, every innovation starts with one goal, leveling up the fan experience and bringing people closer to the game they love.” 

“This is what IMAX Enhanced was built for,” said Giovanni Dolci, Chief Commercial Officer at IMAX. “A fan-first, best-in-class at-home experience. This pilot demonstrates that IMAX’s innovative entertainment technology scales for the speed and spectacle of live sports. Higher engagement is good business for both rights owners and rights holders. And with partners like Victory+, who move fast, we’re proud that just months after announcing our expansion to live, we’ve already brought this milestone to consumers.”

Engagement Highlights
- An average of 39,049 viewers streamed the series in IMAX Enhanced on a per game basis
- The stream was made available on UHD compatible Roku, Samsung, LG, Vizio and Vidaa devices
- The Rangers pilot games drew an average of approximately 72,650 total viewers on the Victory+ platform.
Today’s announcement marks the latest evolution in the sports streamer’s ongoing commitment to pushing boundaries and breaking barriers in live sports streaming. Since the launch of Victory+ just over a year ago, the platform has continued to elevate the fan experience, redefining how audiences connect with the game. Recognized with five Lone Star Emmy nominations in its inaugural season, and strong viewership numbers, Victory+ has quickly established itself as a leading player in the sports streaming landscape, winning over fans and partners alike.

ABOUT APMC

A Parent Media Co. Inc (APMC) is a global technology company building audience-first products that connect millions of people across the world with the brands they love. With a diverse portfolio of free, ad-supported products that include platforms Kidoodle.TV®, Dude Perfect Streaming Service, Glitch+™, Victory+™, and groundbreaking ad technology Safe Exchange™ APMC delivers brand-safe media that builds meaningful connections.

Powered by advanced streaming infrastructure, APMC platforms engage audiences across thousands of devices in more than 160 countries-redefining global reach. By combining flexible monetization models, real-time audience insights, and customizable brand integrations, the APMC network empowers partners to accelerate growth and unlock new revenue at scale.

APMC is challenging outdated models and breaking down barriers, ensuring that everyone, everywhere can access the content they love.

ABOUT Victory+

Victory+ is a free, sports streaming platform that puts fans first, giving them direct access to the teams and leagues they love. It features regional broadcasts of teams including the Dallas Stars, Anaheim Ducks, and Texas Rangers, along with national coverage of highly popular leagues such as the WHL and NWSL. Victory+ is also the home to a library of on-demand, premium sports-based, outdoors, and extreme sports content.

Learn more at www.victoryplus.com and www.aparentmedia.com

Media Contact: media@aparentmedia.com

ABOUT IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX’s network among the most important and successful theatrical distribution platforms for major event films around the globe.  

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of June 30, 2025, there were 1,821 IMAX systems (1,750 commercial multiplexes, 11 commercial destinations, 60 institutional) operating in 89 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970”. 

IMAX^®, IMAX 3D^®, Experience It In IMAX^®, The IMAX Experience^®, DMR^®, Filmed For IMAX^®, IMAX LIVE™, IMAX Enhanced^® and VisionScience™ are trademarks and trade names of IMAX Corporation or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit www.imax.com. You may also connect with IMAX on Instagram (www.instagram.com/imax), Facebook (www.facebook.com/imax), LinkedIn (www.linkedin.com/company/imax), X (www.twitter.com/imax), and YouTube (www.youtube.com/imaxmovies). 

Contact Information

Madeleine Moench
madeleine@newswire.com

Jeremy Mason
Chief Brand Officer
media@aparentmedia.com

SOURCE: A Parent Media Co. Inc.

Related Images

View the original press release on ACCESS Newswire
October 23, 2025
Ginza Diamond Shiraishi Hong Kong Highlights the Craftsmanship and Symbolism Behind Diamond Rings

Causeway Bay, HK – October 17, 2025 – PRESSADVANTAGE –

Ginza Diamond Shiraishi Hong Kong has issued a detailed overview exploring the evolving artistry, craftsmanship, and symbolism behind its collection of 鑽石戒指 (diamond rings). The announcement aims to highlight the methods and philosophy that guide the brand’s approach to ring design and production, reflecting its continuing role in Hong Kong’s fine jewelry landscape.

The brand’s new initiative focuses on documenting and communicating the processes that define the structure and aesthetic of a modern wedding ring. The study includes information about sourcing, design methodology, precision cutting, and the cultural context of diamond rings creation. According to the company’s design division, the purpose is to help customers, collectors, and industry observers understand the balance between material science and emotional symbolism that each ring represents.

Each diamond ring produced under the Ginza Diamond Shiraishi name is based on an in-house design language emphasizing precision geometry and light performance. The diamond setting is adjusted to achieve optimal brilliance under natural and artificial light conditions, while maintaining minimal interference with the stone’s inherent symmetry. This design logic is the result of iterative collaboration between gemologists, designers, and metal artisans who evaluate how light travels within and beyond the stone.

The company’s production team has also provided details about its quality management framework. Stones undergo multiple inspection stages to confirm cut accuracy, clarity consistency, and color calibration. In recent years, attention has also been directed to traceability—ensuring that each diamond can be traced to a verified and ethically responsible source. These measures align with global standards for responsible sourcing and are monitored through a network of certified suppliers and independent evaluators.

The metals used in the brand’s wedding ring settings are selected based on durability and compatibility with the optical behavior of the diamonds. Alloys are adjusted to achieve specific tonal warmth—yellow gold, rose gold, and platinum are formulated with slight compositional variations to harmonize with the brilliance and color of the mounted stone. This technical approach aims to preserve long-term luster and minimize surface wear, an aspect regarded as essential in jewelry that represents permanence.

From a design perspective, Ginza Diamond Shiraishi Hong Kong continues to employ both traditional and contemporary design processes. Initial sketches are created by hand, maintaining an artistic interpretation of each collection’s theme. These are followed by digital modeling stages where engineers simulate the balance, weight, and comfort of the ring. The result combines aesthetic fluidity with structural stability, ensuring that every diamond ring performs both as a symbol and as a precise engineered object.

Industry observers have noted that demand for 鑽石戒指 (diamond rings) continues to evolve beyond simple aesthetic value. The modern consumer increasingly seeks transparency in sourcing, personalization options, and lasting durability. Ginza Diamond Shiraishi Hong Kong’s focus on educational initiatives and process documentation responds to these shifts by providing verifiable insight into the material and ethical standards of its products.

The announcement also covers recent research by the company’s gemological division, which investigates how microvariations in cut proportion influence light return and dispersion. Data from these studies have been applied to optimize the angular design of selected ring settings, improving perceived brightness and color fire. According to the internal report, even minor adjustments of less than one degree in pavilion angle or crown height can meaningfully alter light diffusion within a diamond ring, reinforcing the brand’s emphasis on scientific precision in jewelry design.

The firm’s workshop continues to function as both a production facility and a training environment. Artisans are instructed in metal shaping, micro-setting, and finishing techniques that require precision to the tenth of a millimeter. Through this dual-purpose structure, Ginza Diamond Shiraishi maintains consistency across its output while passing technical knowledge to emerging craftsmen. The company believes this balance between tradition and innovation is essential for sustaining quality standards in fine jewelry manufacturing.

To further strengthen customer understanding, the brand has also enhanced its consultation process. Prospective clients can now access design demonstrations showing how minor changes in diamond size, band curvature, or setting height affect both visual and ergonomic qualities. While the initiative is not promotional in nature, it contributes to broader literacy around jewelry design and helps customers make informed decisions based on measurable factors rather than aesthetic preference alone.

The report includes commentary from independent jewelry analysts who observe that 鑽石戒指 (diamond rings) remain among the most technically sophisticated items in luxury design due to their optical complexity and emotional significance. They note that brands capable of integrating craftsmanship with educational transparency are increasingly regarded as leaders in the field. Ginza Diamond Shiraishi’s initiative reflects this perspective by combining detailed production disclosure with a commitment to preserving design integrity.

In addition to physical craftsmanship, the company has introduced digital archiving methods for each ring’s lifecycle documentation. This includes design specifications, sourcing certificates, and quality assurance records. Stored securely, this data allows long-term verification of each piece’s authenticity and material origin. Such documentation practices correspond with industry trends emphasizing digital provenance and responsible ownership verification.

The new documentation and communication measures do not alter the company’s product range but instead provide an updated framework for understanding the diamond ring as both an artistic and technical object. The approach aligns with a broader movement within the jewelry sector toward accountability, traceability, and respect for traditional craftsmanship.

Ginza Diamond Shiraishi Hong Kong’s statement concludes by reiterating its position that a wedding ring represents not only craftsmanship but also shared meaning. Through the integration of design discipline, material science, and ethical production, the company aims to preserve the essence of the diamond rings as a lasting symbol of connection while promoting deeper awareness of the processes that give it form.

The information outlined in the announcement reflects the brand’s ongoing dedication to combining artistry with responsibility—core attributes that define its contribution to the international jewelry community. The initiative also illustrates how precision in production and clarity in communication can coexist to maintain public trust in the value and authenticity of the diamond ring tradition.

For more information, please read:

https://pressadvantage.com/story/83942-ginza-diamond-shiraishi-hong-kong-highlights-commitment-to-engagement-ring-craft-and-consumer-trends

###

For more information about Ginza Diamond Shiraishi Causeway Bay 銀座白石銅鑼灣, contact the company here:

Ginza Diamond Shiraishi Causeway Bay 銀座白石銅鑼灣
Mr. Shiraishi
(852) 2787 0606
admin@diamond-shiraishi.hk
Shop G29-30, Fashion Walk, 11-19 Great George Street, Causeway Bay, Hong Kong

October 23, 2025
New York’s Amelia Home Care Raises Awareness Of New OPWDD Initiatives In 2025

The New York Office for People With Developmental Disabilities (OPWDD) is tasked with supporting over 40,000 New York residents of all ages as they attempt to secure necessary healthcare and other support services. Key changes have been implemented to their programs in 2025, however, and as such, the providers who fulfill those care needs are increasing their outreach efforts to ensure that patients fully understand the services available to them.

One such provider, New York-based Amelia Home Care, has created an entire section on their website dedicated to OPWDD benefits, and they aren’t the only ones. By the Office’s own count, they are partnered with over 500 certified providers as they attempt to ensure widespread access to disability care, and it is largely contingent on those providers to make clear the benefits they do and do not offer.

Recent Changes

As for the exact changes that sparked this widespread effort, one might point to the Pathway To Employment initiative as the most important—or, at least, the most substantial. The initiative sets new, expanded guidelines for providers, such as Amelia Home Care, who act as full or part-time caregivers to those with disabilities. Those providers must now take meaningful steps to ensure that the employment goals of their patients are met; steps which are outlined in the OPWDD documentation.

Another change critically relevant to patients comes in relation to the Home Enabling Support Waiver, a state-funded program designed to expand access to mobility aids and other accessibility measures. In brief, the changes allow waiver recipients to invest in newly classified “Assistive Technologies”, essentially ensuring that multiple measures can be covered by the same waiver in the same year.

The Role Of Outreach

What these two major changes to the OPWDD’s guidelines have in common is their relative obscurity, even within official documentation. While amendments are highlighted on a yearly basis, no effort has been made by the Office itself to make this information broadly accessible or legible to the layperson, further underscoring the role of healthcare providers in this process.

To their credit, the Office does provide assistance in matching patients and their families with care management companies across the state. As long as this symbiotic relationship is maintained, it remains true that New York will continue to effectively address accessibility challenges as they arise.

Amelia Home Care

3007 Ocean Parkway
1st floor
Brooklyn
New York
11235
United States

October 23, 2025
GenHealth.ai and Guidehealth Achieve Up to 60% Reduction in Utilization Management Workload Through AI-Native Platform
GenHealth.ai and Guidehealth achieved up to a 60% reduction in Utilization Management workload using GenHealth’s AI-native platform, leading to $1.2M in annual savings. The system automates clinical data extraction and policy evaluations, improving efficiency, compliance, and decision consistency above 90%.

BOSTON, MA / ACCESS Newswire / October 17, 2025 / GenHealth.ai, a leader in AI-native healthcare automation, today announced the successful deployment of its AI-driven Utilization Management (UM) and Prior Authorization (PA) platform with Guidehealth, an At Risk Managed Services Organization (MSO). The collaboration resulted in up to 60% reduction in UM workload across multiple care settings, significantly improving efficiency, compliance, and an estimated annual cost savings of $1.2m.

GenHealth.ai x Guidehealth

GenHealth’s AI-native UM platform integrates seamlessly with existing medical guidelines, administrative policies, and provider portals to automate data intake, escalation logic, and decision recommendations-without disrupting existing workflows. During the initial pilot nearly thousands of cases were processed in 4 months before further expansion.

“Healthcare utilization management has long been constrained by manual review and fragmented workflows,” said Ethan Siegel, Co-Founder of GenHealth.ai. “Our work with Guidehealth proves that AI can dramatically streamline these processes while maintaining trust, transparency, and full regulatory compliance.”

Transforming Utilization Management with Human-Centered AI

GenHealth’s solution leverages Large Language Models (LLMs) and predictive algorithms to interpret and apply complex medical and administrative policies. The system automatically extracts, summarizes, and structures clinical data from PDFs, faxes, and call center transcripts-reducing RN manual review time by an average of one hour per Skilled Nursing Facility (SNF) case and accelerating medical policy evaluations to under ten minutes per case.

Each AI-generated recommendation includes detailed citations for every decision step, ensuring complete auditability and compliance with CMS, NCQA, and state-level regulations.

Key Results and Impact
- Up to 60% workload reduction across utilization management teams
- 90%+ consistency in decision-making, improving fairness and reducing provider abrasion
- ~$1.2 million projected annual cost savings across multiple IPAs
- Full compliance and transparency in AI-assisted medical decision-making
“These results are just the beginning,” said Ricky Sahu, CEO and Co-Founder of GenHealth.ai. “As we expand our UM automation capabilities into behavioral health, concurrent review, and SUD services, the impact on efficiency and patient access to care will multiply.”

Download the full case study to learn more about the implementation details and outcomes here.

About GenHealth.ai

GenHealth.ai builds AI-native infrastructure for healthcare organizations, empowering payers and providers to automate utilization management, prior authorization, and clinical review processes. By combining large medical models, predictive analytics, and human-centered design, GenHealth enables clients to streamline operations, ensure compliance, and improve patient outcomes.

For more information, visit www.genhealth.ai.

About Guidehealth

Guidehealth is an At Risk Managed Services Organization (MSO) that partners with Independent Physician Associations (IPAs) and provider networks to improve care quality and operational efficiency. The company specializes in value-based care programs, utilization management, and provider engagement strategies. Guidehealth leverages technology and data-driven insights to optimize patient outcomes while supporting clinicians in delivering coordinated, high-quality care

Contact Information

Mike Maseda
Head of Sales & Operations
marketing@genhealth.ai

SOURCE: Genhealth AI

View the original press release on ACCESS Newswire
October 23, 2025